ANDA 88214, held by Allergan Herbert. Hydrocortisone.
As of Nov 14, 2026, ANDA 88214 (Penecort), held by Allergan Herbert, was first approved by FDA on Jun 6, 1984, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 6, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Penecort1% ยท solution;topical | Hydrocortisone | DiscontinuedReference drug |
| May 21, 1999 | Supplement 8Manufacturing | Approved | None posted |
| Dec 9, 1998 | Supplement 7Manufacturing | Approved | None posted |
| Apr 7, 1998 | Supplement 6Manufacturing | Approved | None posted |
| Feb 19, 1986 | Supplement 4Manufacturing | Approved | None posted |
| Feb 19, 1986 | Supplement 5Manufacturing | Approved | None posted |
| Mar 6, 1985 | Supplement 1Manufacturing | Approved | None posted |
| Jun 6, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters